Outcome of clinical congestive heart failure induced by anthracycline chemotherapy
- 1 December 1992
- Vol. 70 (11) , 2637-2641
- https://doi.org/10.1002/1097-0142(19921201)70:11<2637::aid-cncr2820701112>3.0.co;2-p
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Reversibility of Severe Left Ventricular Dysfunction Due to Doxorubicin CardiotoxicityAnnals of Internal Medicine, 1987
- Prospective Study of Cardiomyopathy Induced by Adjuvant Doxorubicin Therapy in Patients With Soft-Tissue SarcomasArchives of Surgery, 1986
- Chronic anthracycline cardiotoxicity: haemodynamic and histopathological manifestations suggesting a restrictive endomyocardial disease.Heart, 1986
- Doxorubicin cardiotoxicityCancer Treatment Reviews, 1982
- Congestive heart failure due to adriamycin cardiotoxicity: Its natural history in childrenCancer, 1981
- Adriamycin cardiotoxicityAmerican Heart Journal, 1980
- Risk Factors for Doxorubicin-lnduced Congestive Heart FailureAnnals of Internal Medicine, 1979
- Adriamycin cardiomyopathy—risk factorsCancer, 1977
- Cardiotoxicity of adriamycin and related anthracyclinesCancer Treatment Reviews, 1976
- A clinicopathologic analysis of adriamycin cardiotoxicityCancer, 1973